Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Accounts Payables (2016 - 2026)

Orthopediatrics has reported Accounts Payables over the past 11 years, most recently at $19.7 million for Q1 2026.

  • For Q1 2026, Accounts Payables rose 38.75% year-over-year to $19.7 million; the TTM value through Mar 2026 reached $19.7 million, up 38.75%, while the annual FY2025 figure was $18.8 million, 110.89% up from the prior year.
  • Accounts Payables for Q1 2026 was $19.7 million at Orthopediatrics, up from $18.8 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $22.6 million in Q3 2023 and troughed at $7.2 million in Q3 2025.
  • A 5-year average of $14.9 million and a median of $14.6 million in 2022 define the central range for Accounts Payables.
  • Biggest five-year swings in Accounts Payables: crashed 48.43% in 2024 and later surged 110.89% in 2025.
  • Year by year, Accounts Payables stood at $11.2 million in 2022, then increased by 13.44% to $12.6 million in 2023, then dropped by 29.58% to $8.9 million in 2024, then surged by 110.89% to $18.8 million in 2025, then grew by 4.87% to $19.7 million in 2026.
  • Business Quant data shows Accounts Payables for KIDS at $19.7 million in Q1 2026, $18.8 million in Q4 2025, and $7.2 million in Q3 2025.